North America Medical Nutrition Market Outlook to 2030: Size, Share, Growth and Trends

The North America Medical Nutrition Market was valued at USD 16,500 Mn in 2024 on a manufacturer revenue, ex-factory, constant-2024-USD basis. That base includes oral nutritional supplements, enteral nutrition, parenteral nutrition, pediatric specialty nutrition, texture-modified nutrition, and home enteral services and devices. Commercially, this is a meaningful healthcare market rather than a niche wellness category because spending is tied to medically supervised use cases, hospital protocols, chronic disease management, and reimbursed home nutrition pathways. The market’s revenue quality is also supported by strong exposure to higher-acuity and disease-linked formulations.

The North America Medical Nutrition Market is projected to reach USD 23,366 Mn by 2030 , implying a 5.97% CAGR during 2025-2030 . This pace is credible rather than aggressive; it is supported by chronic disease prevalence, elder-care demand, disease-specific formula adoption, and expanding home-based nutrition models. The forecast also assumes continued price realization from mix improvement, not only volume expansion. In parallel, volume is expected to rise from 1,420 million units in 2024 to roughly 1,913 million units in 2030 , indicating continued physical demand alongside moderate premiumization.

Profit pools are gradually shifting away from standard, lower-differentiation nutrition toward disease-specific formulas, pediatric specialty nutrition, and service-linked home enteral models. Oral Nutritional Supplements remain the largest segment at USD 4,785 Mn in 2024 , but Disease-Specific Enteral Formulas are the fastest-growing at 7.4% CAGR . That matters because specialized products usually benefit from stronger clinical rationale, lower direct substitutability, and better pricing support. Home-linked models also increase recurring revenue through devices, administration sets, reimbursement support, and refill continuity, which can improve customer stickiness and channel economics.

The main risk is not end-demand collapse; it is execution risk around reimbursement, sterile manufacturing, and channel continuity. PN and HEN categories are especially exposed because claims accuracy, medical-necessity documentation, and supply reliability directly affect realized revenue. Standard Enteral Nutrition is the slowest-growing segment at 3.8% CAGR , which means undifferentiated portfolios face more pricing pressure. At the same time, concentrated supply in capital-intensive categories increases the impact of disruptions, while payer scrutiny can turn nominal demand into delayed cash conversion if operational processes are weak.

Demand is highly concentrated in the United States, which accounts for roughly 82% of the 2024 North America Medical Nutrition Market . Canada represents about 12% and Mexico about 6% . This concentration is strategically important because the United States largely sets regional pricing logic, reimbursement conventions, and hospital-to-home transition models. Canada offers steadier public-sector demand, while Mexico provides a smaller current base but higher long-term headroom where clinical access improves. For most manufacturers, North American scale is functionally a U.S.-led operating model with targeted expansion layers rather than three equally weighted country plays.

Three structural drivers matter most: aging, chronic disease, and clinical migration toward managed nutrition in both hospital and home settings. In the United States, older adults continue to expand as a share of the population, while diabetes, kidney disease, oncology, and neurologic conditions all enlarge the addressable need for medically supervised nutrition. These drivers improve the outlook for both oral and enteral categories, especially where products reduce complications, support recovery, or enable discharge continuity. Demand is therefore linked to health-system utilization and disease burden, which makes it less discretionary than mainstream consumer nutrition markets.